Search »
Search tips
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Filters
Content type
Topic Areas
Source
Publication Date
Found 268 results.
-
-
Webinars on Demand: Medicare and Medicare-Medicaid Dual Eligibility for RWHAP Clients
ACE TA Center webinars covering Medicare and Medicare-Medicaid dual eligibility for RWHAP clients.News Article updated on 04/15/2024 -
Hepatitis Rates Improve Across the Board: CDC Surveillance Report
Rates of hepatitis, across the ABC alphabet, have declined in recent years, according to the 2022 Viral Hepatitis Surveillance Report (CDC, April 2024).News Article updated on 04/09/2024 -
Over 50,000 Health Professionals Trained: AETC 2022 Report
In 2021-2022, 56,383 health professionals received training in HIV clinical topics, provided by the HIV clinical training network under HRSA's Ryan White HIV/AIDS Program.News Article updated on 05/06/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
AETC May Roundup: Slides, Slides, Quiz, and a Winner
There is no shortage of HIV clinical training slides, featured in the May 2024 update from the AETC National Coordinating Resource Center.News Article updated on 05/21/2024 -
Quick Reference Guide: Access to Health Coverage for Immigrants Living with HIV
Are you working with immigrants living with HIV who need health coverage?
Use this quick reference guide to learn about the following topics:
- Eligibility of immigrants for health coverage
- Eligibility of immigrants for financial assistance
- Verification of identity and immigration/citizenship status
- Resources for immigrants not eligible for Medicaid or Marketplace coverage
- Concerns about immigration enforcement
Resource updated 05/29/2024
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024